Stock Analiz

Altimmune, Inc. (ALT) stock forecast and price target

Price $1.65 · data as of November 13, 2026

12-month price target

Average target$16.33
Upside / downside+892.9%
Analysts9
ConsensusStrong buy
Low $11.00Average $16.33High $26.00

Gold marker: average target · white marker: today’s price ($1.65)

Analyst ratings

Strong buy 2Buy 7Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.63+37.2%$0
Next fiscal year
ends December 31, 2027
$-0.69−10.7%$0
Next quarter
ends December 31, 2026
$-0.18+34.1%$0
Quarter after
ends March 31, 2027
$-0.16+8.9%$0

Consensus of the analysts covering Altimmune, updated daily.

Frequently asked questions

What is the Altimmune stock price target?

The average 12-month target from 9 analysts is $16.33, 892.9% above the current price of $1.65 Targets range from $11.00 to $26.00.

Is Altimmune a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 7 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Altimmune expected to earn?

Analysts expect EPS of $-0.63 for the fiscal year ending December 31, 2026 and $-0.69 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.